Affecting as many as 500,000 Americans, bronchiectasis (BE) is an under-diagnosed chronic lung disease that causes permanent airway damage and retained secretions. Often misdiagnosed as asthma or COPD, BE requires a range of therapeutic interventions, including airway clearance therapy. In this on-demand webinar hosted by RT Magazine, a panel of respiratory and pulmonary experts discussed effective and successful strategies for treating bronchiectasis, including:

  • The clinical impact of bronchiectasis;
  • Treatment options, including pharmacological therapy and airway clearance therapy; and
  • A look at established hospital bronchiectasis programs for successful tips on creating a new program.

Register now to watch the on-demand recording, below.

This webinar was generously sponsored by Tactile Medical.